ReviewInternational journal of molecular sciences2026
Engineering MSC Migration: Roles of Nanoparticles in Activating Migratory Pathways and Functions.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Mesenchymal stem cells (MSCs) hold strong therapeutic potential due to their regenerative, anti-inflammatory, and immunomodulatory properties. A key factor in their effectiveness is the ability to home in to injured sites. However, clinical outcomes are limited by poor homing efficiency, insufficient migration, tracking challenges, and risks of unwanted differentiation. This review explores the molecular mechanisms of MSC homing, particularly the CXCR4/SDF-1 axis and matrix remodeling. We highlight recent advances in using nanoparticles-such as magnetic, silica, and polymer-based systems-to enhance chemokine receptor expression and homing. Future directions include MSC engineering, advanced tracking, and AI-guided delivery strategies to improve therapeutic efficacy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.